Bristol-Myers Squibb Company logo
Bristol-Myers Squibb Company BMY
$ 56.16 -0.14%

Annual report 2025
added 02-11-2026

report update icon

Bristol-Myers Squibb Company P/S Ratio 2011-2026 | BMY

Annual P/S Ratio Bristol-Myers Squibb Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.54 2.36 2.23 3.35 3.26 3.13 5.5 3.54 5.06 4.19 6.26 6.29 5.07 3.47 2.58

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.29 2.23 3.92

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
172 - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Exelixis Exelixis
EXEL
5.05 $ 48.16 4.22 % $ 13.1 B usaUSA
BioNTech SE BioNTech SE
BNTX
35.7 $ 94.13 1.19 % $ 22.8 B germanyGermany
Fortress Biotech Fortress Biotech
FBIO
1.23 $ 2.39 -0.42 % $ 66.7 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
181 $ 24.02 -8.22 % $ 311 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
49.8 $ 2.9 1.4 % $ 271 M israelIsrael
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
3.33 $ 22.4 -0.71 % $ 3.71 B usaUSA
Genmab A/S Genmab A/S
GMAB
15.6 $ 26.43 -2.33 % $ 1.71 B danmarkDanmark
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
1.39 $ 3.14 - $ 653 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
759 $ 3.51 -0.85 % $ 5.78 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
Gilead Sciences Gilead Sciences
GILD
6.23 $ 131.33 -2.04 % $ 163 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
204 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
13.3 - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
9.15 $ 21.17 2.47 % $ 2.69 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
106 - -11.43 % $ 502 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
0.627 $ 8.1 0.5 % $ 5.51 B spainSpain
Applied Therapeutics Applied Therapeutics
APLT
54.1 - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
6.61 - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
1.34 - 17.91 % $ 11.1 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.25 K $ 54.83 4.6 % $ 4.93 B schweizSchweiz
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.27 $ 1.57 -2.48 % $ 418 M britainBritain